This post was originally published on News-medical.net
You will shortly be re-directed to the publisher's website
A major new research trial led by academics at the University of East Anglia (UEA) and taking place at eight major stroke centres across England, will test the efficacy of a new therapy for a disabling post-stroke condition that affects around one in three survivors, thanks to a £1.26m grant from the Efficacy and Mechanism Evaluation (EME) Programme – a partnership between the National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC).